demonstrated increased expression of ADAM metallopeptidase domain 17 (ADAM17), or TNF-α converting enzyme (TACE), in reactive astrocytes within active white matter lesions in MS patients. The gene discussed is ADAM17; the disease is myeloid sarcoma.